Novartis is expanding its prospects in cardiometabolic disease by striking a deal to acquire Anthos Therapeutics, a company in pivotal testing with a blood clot-preventing drug that could offer ...
Brits taking a commonly prescribed medicine have been warned about four potential side effects. The NHS notes these symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback